The American College of Chest Physicians (CHEST) recently released new clinical guidelines for venous thromboembolism (VTE) management, "Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert ...
Aug 4, 2021
0
313
(HealthDay)—Children with inflammatory bowel disease (IBD) have a higher risk for venous thromboembolism (VTE), according to a study published online June 27 in the Journal of Crohn's & Colitis.
Jul 27, 2021
0
4
(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is increased after unprovoked ...
Jul 23, 2021
0
4
(HealthDay)—A new draft recommendation relating to anticoagulation for discharged patients with COVID-19 has been issued by the American Society of Hematology (ASH).
Jul 20, 2021
0
2
In addition to sickening and taking the lives of millions across the globe, COVID-19 complicated patient care in a range of less-direct ways, from increased incidence of heart attacks to decreased cancer screenings. The virus ...
Jun 28, 2021
0
3
(HealthDay)—Prophylactic-dose venous thromboembolism (VTE) anticoagulation may be optimal therapy for patients hospitalized with COVID-19, according to a study published online June 11 in JAMA Network Open.
Jun 23, 2021
0
0
(HealthDay)—The first oral blood thinning medication for children was approved by the U.S. Food and Drug Administration, the agency announced Monday.
Jun 23, 2021
0
3
(HealthDay)—The risk for severe postacute complications is low after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection not requiring hospitalization, according to a study published online May 10 in ...
May 17, 2021
0
2
A new study presented today at the AATS 101st Annual Meeting, found that the percentage of patients undergoing esophagectomy for cancer who suffer Venous Thromboembolism (VTE) post-operatively is much higher than previously ...
May 2, 2021
0
6
(HealthDay)—Patients with cancer receiving immune checkpoint inhibitor treatment are at high risk for thromboembolism, especially venous thromboembolism (VTE), according to a study published online March 25 in Blood.
Apr 26, 2021
0
5
